Promiliad Biopharma is an innovative drug discovery company that creates novel natural
product-like small molecules in combinatorial arrays. Promiliad has developed a
proprietary and unique approach to the drug discovery process, a technology called
ReBACS (Recombinant Biotechnology Assisted Combinatorial Synthesis). The natural
product-based feedstock generated by ReBACS offers a complex and rich structural
diversity, simplifies the synthetic challenge in drug discovery and increases the
probability of generating new lead compounds. We facilitate the identification of
lead compounds, the preparation of focused libraries and the efficient scale up of
lead production.
Based on our natural product-like compound arrays, Promiliad Biopharma has established
internal drug discovery programs that are focused on the development of new
antibacterial and antifungal agents.